Valneva's COVID-19 Vaccine Hopes Almost Over Before They Start
Europe Slashes Supply Deal
Executive Summary
Rather than terminating a deal for the French biotech's VLA2001 vaccine, the European Commission has put in a tiny order of 1.25 million doses which could bring the curtain down on Valneva's COVID-19 programs.